Stay updated on EAP Avapritinib in Advanced GIST Clinical Trial
Sign up to get notified when there's something new on the EAP Avapritinib in Advanced GIST Clinical Trial page.

Latest updates to the EAP Avapritinib in Advanced GIST Clinical Trial page
- Check3 days agoChange DetectedA government funding/status notice was added and the page revision updated from v3.4.0 to v3.4.1.SummaryDifference0.7%

- Check10 days agoChange DetectedThe new page adds a Show glossary option and updates header/footer text, including Last Update Submitted that Met QC Criteria, No FEAR Act Data, and Revision: v3.4.0, replacing the previous wording and version (v3.3.4).SummaryDifference0.3%

- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedPage revision updated from v3.3.3 to v3.3.4.SummaryDifference0.1%

- Check45 days agoChange DetectedFooter now displays Revision: v3.3.3. The HHS Vulnerability Disclosure and Revision: v3.3.2 references were removed.SummaryDifference0.2%

- Check74 days agoChange DetectedThe page shows a revision update from v3.2.0 to v3.3.2. This change does not affect the study content or its presentation.SummaryDifference0.1%

- Check81 days agoChange DetectedRemoved the government funding and operating status notice from the page (including references to cc.nih.gov and opm.gov). This does not affect the displayed study details or eligibility information.SummaryDifference0.6%

Stay in the know with updates to EAP Avapritinib in Advanced GIST Clinical Trial
Enter your email address, and we'll notify you when there's something new on the EAP Avapritinib in Advanced GIST Clinical Trial page.